跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
替莫唑胺胶囊 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Temozolomide Capsules
Approved
化学药品
Temozolomide Capsules
Merck Sharp & Dohme BV
🇨🇳 National Medical Products Administration
Approval Date
Jan 6, 2022
Approval ID
8DqcEqzr8Nk
Company
Merck Sharp & Dohme BV
Type
化学药品
Approval Details
Approval Id
8DqcEqzr8Nk
Approval Number
国药准字HJ20171091
Generic Name
替莫唑胺胶囊
Generic Name En
Temozolomide Capsules
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
100mg
Reg Date
2022-01-06
Expired Date
2027-01-05
Company Name
Merck Sharp & Dohme BV
Production Company Name
ORION CORPORATION
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Production Company Detail Path
/organization/orion-corporation
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 6, 2022
Approval ID
8DqcEqzr8Nk
Type
化学药品
Back to NMPA Approvals